ODDITY Invests $100M to Bring Pharma's AI Based Molecule Dis

With the acquisition of Boston-based Revela, a leading biotech startup, and the establishment of ODDITY LABS, the company is at the vanguard, bringing a proven drug discovery technology into beauty

Related Keywords

Tel Aviv , Israel , Toronto , Ontario , Canada , New York , United States , Harvard University , Massachusetts , Massachusetts Institute Of Technology , Boston , Oran Holtzman , Connor Coley , Robertp Pinkas , Evan Zhao , David Mooney , Ying Tung Evelyn Chen , Avinash Boppana , Ravi Boppana , David Zhang , Michael Braun , Henri Slezynger , Harvard Medical School , Nature Communications , Sciences At Harvard University , University Of Toronto , Massachusetts Institute Of Technology Revela , Harvard Johna Paulson School Of Engineering , Maeder Graduate Fellow In Energy , Princeton University , Mcgill University , Boston Based Revela , Artificial Intelligence Based , Shiran Holtzman Erel , Business Wire , Chief Scientific , Based Molecule Discovery , Khosla Ventures , Montage Ventures , Ying Tung , Chemical Engineering , Maeder Graduate Fellow , Nature Biotechnology , Nature Chemical Biology , Schmidt Science Fellow , Rhodes Trust , Wyss Institute , Biologically Inspired Engineering , Nature Materials , Professor David Mooney , Family Professor , Harvard John , Applied Sciences , Nature Cell Biology , Professor Connor Coley , Career Development Assistant Professor , Chemical Engineering Electrical , Computer Science , Massachusetts Institute , Technology Revela , New York City , Machine Learning Driven , Oddity , Nvests , 00m , Ring , Dharma , Ased , Olecule , Discovery , Technology , Beauty , Wellness ,